| Breast Cancer |
1 |
1 |
| Selective Estrogen Receptor Modulators |
0 |
0.63 |
| Advanced and Metastatic Breast Cancer |
0 |
0.61 |
| BRCA |
0 |
0.45 |
| Genomic Medicine |
0 |
0.41 |
| Breast |
0 |
0.39 |
| Cancer |
0 |
0.34 |
| Mastectomy |
0 |
0.28 |
| Thromboembolism |
0 |
0.24 |
| Frailty |
0 |
0.22 |
| Lumpectomy |
0 |
0.22 |
| Genetics |
0 |
0.17 |
| Pulmonary Embolism |
0 |
0.13 |
| Epidermal Growth Factor Receptor |
0 |
0.12 |
| Receptors |
0 |
0.11 |
| Deep Venous Thrombosis |
0 |
0.08 |
| Ductal carcinoma in situ |
0 |
0.08 |
| Chemotherapy |
0 |
0.06 |
| Embolism |
0 |
0.06 |
| Endocrine Therapy |
0 |
0.06 |
| Poly ADP-Ribose Polymerase (PARP) Inhibitor |
0 |
0.06 |
| Surgery |
0 |
0.06 |
| Thrombosis |
0 |
0.06 |
| Vein |
0 |
0.06 |